Cellectar Biosciences Inc Files For Shelf Of Up To 34.5M Shares Of Common Stock By Selling Stockholders
Portfolio Pulse from Benzinga Newsdesk
Cellectar Biosciences Inc has filed for a shelf of up to 34.5 million shares of common stock by selling stockholders, according to an SEC filing.
October 05, 2023 | 8:50 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cellectar Biosciences' filing for a shelf of up to 34.5 million shares could potentially dilute the value of existing shares, impacting the stock price.
The filing for a shelf of up to 34.5 million shares by Cellectar Biosciences could lead to dilution of the value of existing shares if these new shares are issued. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100